Pfizer Inc. conducted an intriguing experiment in brand marketing this year, aggressively pushing the cholesterol-fighting drug Lipitor in the U.S. even after its patent expired on Nov. 30. But after spending more than $87 million promoting the medicine, the world's biggest drug company is quietly...
FULL ARTICLE AT Asian Wall Street Journal